Sign in

CIK 0001840229 · <br>Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. DEF 14A Proxy Proxy Statement
  2. 10-K Report Annual Report
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 8-K Event Executive or director change
  9. SC 13G Stake Amended Statement of Ownership
  10. 5 Insider Annual Insider Trading Report
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 8-K Event Executive or director change
  14. 10-Q Report Quarterly Report
  15. SC 13D Stake Beneficial Ownership Report
  16. 4 Insider Changes in Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 12 of 14 · 267 filings